Journal of Antimicrobial Chemotherapy · 2011 · 269 citations · 11 references
Life SciencesMicrobiologyMolecular GeneticsBacteriologyMedical MicrobiologyMicrobial GeneticsAntibiotic ResistanceAntibiotic Resistance GeneticsBacterial EpidemiologyBacterial GeneticsBacterial InfectionsMolecular TypingBacterial TypingGenotypic Characterization Of IsolatesMolecular Typing Of BacteriaMolecular Typing Of IsolatesMolecular Typing Of PathogensMolecular Typing Of Resistant IsolatesPlasmid Gene TransferResistance Plasmid Transfer
OBJECTIVES: To investigate the prevalence of bla(NDM-1) in Gram-negative bacilli in China. METHODS: A total of 11 298 clinical Gram-negative bacilli, covering Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa, were collected for PCR-based surveillance of bla(NDM-1) from 57 hospitals representing 18 provinces in China. For bla(NDM-1)-positive isolates, antibiotic susceptibilities were assessed and molecular typing was performed using PFGE. The genetic location of bla(NDM-1) was determined by analysis of PFGE profiles of S1 nuclease-digested genomic DNA and Southern blot hybridization. Plasmid transfer to E. coli recipients was investigated using filter mating and electroporation. RESULTS: Four A. baumannii isolates with bla(NDM-1) were identified in four different provinces in China: no positive isolates were detected among E. coli, K. pneumoniae and P. aeruginosa. These bla(NDM-1)-positive A. baumannii were resistant to all carbapenems and cephalosporins, and three remained susceptible to fluoroquinolones, aminoglycosides and colistin. The four NDM-1-producing A. baumannii were clonally diverse and carried bla(NDM-1) on different plasmids. Plasmids carrying bla(NDM-1) were successfully transferred from three of the four isolates to E. coli recipients, although the transconjugants and transformants were prone to lose the transferred plasmids after passage in the absence of ampicillin selection. CONCLUSIONS: We describe the emergence of A. baumannii producing NDM-1 in China. Systemic surveillance network should be established for monitoring these resistant bacteria.
11
Kanimozhi Kumarasamy, Mark A. Toleman, Timothy R. Walsh et al. · The Lancet Infectious Diseases · 2010 · 2.9K citations · Full text
Dongeun Yong, Mark A. Toleman, Christian G. Giske et al. · Antimicrobial Agents and Chemotherapy · 2009 · 2.4K citations · Full text
Kyungwon Lee, Jong Hwa Yum, Dongeun Yong et al. · Antimicrobial Agents and Chemotherapy · 2005 · 326 citations · Full text
Hsien Chang Chang, Yu Fang Wei, Lenie Dijkshoorn et al. · Journal of Clinical Microbiology · 2005 · 260 citations · Full text
Life Sciences, Biology, Microbiology +17